BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26054318)

  • 41. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era.
    Herregods TV; Bredenoord AJ; Smout AJ
    Neurogastroenterol Motil; 2015 Sep; 27(9):1202-13. PubMed ID: 26053301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antireflux operation for gastroesophageal reflux after Roux-en-y gastric bypass for obesity.
    Chen RH; Lautz D; Gilbert RJ; Bueno R
    Ann Thorac Surg; 2005 Nov; 80(5):1938-40. PubMed ID: 16242496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel endoscopic submucosal dissection technique for proton pump inhibitor-refractory gastroesophageal reflux disease.
    Ota K; Takeuchi T; Harada S; Edogawa S; Kojima Y; Inoue T; Higuchi K
    Scand J Gastroenterol; 2014 Dec; 49(12):1409-13. PubMed ID: 25384555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastroesophageal reflux disease and obesity.
    Anand G; Katz PO
    Rev Gastroenterol Disord; 2008; 8(4):233-9. PubMed ID: 19107097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastro-oesophageal reflux disease in obesity: pathophysiological and therapeutic considerations.
    Barak N; Ehrenpreis ED; Harrison JR; Sitrin MD
    Obes Rev; 2002 Feb; 3(1):9-15. PubMed ID: 12119661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is preoperative manometry in restrictive bariatric procedures necessary?
    Klaus A; Weiss H
    Obes Surg; 2008 Aug; 18(8):1039-42. PubMed ID: 18386106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do we understand the pathophysiology of GERD after sleeve gastrectomy?
    Felinska E; Billeter A; Nickel F; Contin P; Berlth F; Chand B; Grimminger P; Mikami D; Schoppmann SF; Müller-Stich B
    Ann N Y Acad Sci; 2020 Dec; 1482(1):26-35. PubMed ID: 32893342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparoscopic gastric bypass after antireflux surgery for the treatment of gastroesophageal reflux in morbidly obese patients: initial experience.
    Raftopoulos I; Awais O; Courcoulas AP; Luketich JD
    Obes Surg; 2004; 14(10):1373-80. PubMed ID: 15603654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastro-oesophageal reflux disease and obesity: pathogenesis and response to treatment.
    Mion F; Dargent J
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):611-22. PubMed ID: 25194179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiology of gastroesophageal reflux disease.
    Kahrilas PJ; Lee TJ
    Thorac Surg Clin; 2005 Aug; 15(3):323-33. PubMed ID: 16104123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vertical gastrectomy and gastric bypass in Roux-en-Y induce postoperative gastroesophageal reflux disease?
    Nassif PA; Malafaia O; Ribas-Filho JM; Czeczko NG; Garcia RF; Ariede BL
    Arq Bras Cir Dig; 2014; 27 Suppl 1(Suppl 1):63-8. PubMed ID: 25409970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.
    Hunter JG; Kahrilas PJ; Bell RC; Wilson EB; Trad KS; Dolan JP; Perry KA; Oelschlager BK; Soper NJ; Snyder BE; Burch MA; Melvin WS; Reavis KM; Turgeon DG; Hungness ES; Diggs BS
    Gastroenterology; 2015 Feb; 148(2):324-333.e5. PubMed ID: 25448925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients.
    Howard DD; Caban AM; Cendan JC; Ben-David K
    Surg Obes Relat Dis; 2011; 7(6):709-13. PubMed ID: 21955743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How can we deal with the GERD treatment gap?
    Triadafilopoulos G; Azagury D
    Ann N Y Acad Sci; 2016 Oct; 1381(1):14-20. PubMed ID: 27384084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Refractory gastroesophageal reflux disease: advances and treatment.
    Ates F; Francis DO; Vaezi MF
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):657-67. PubMed ID: 24745809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Motor and sensory function of the proximal stomach in reflux disease and after laparoscopic Nissen fundoplication.
    Vu MK; Straathof JW; v d Schaar PJ; Arndt JW; Ringers J; Lamers CB; Masclee AA
    Am J Gastroenterol; 1999 Jun; 94(6):1481-9. PubMed ID: 10364011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is Roux-en-Y gastric bypass safe after previous antireflux surgery? Technical feasibility and postoperative symptom assessment.
    Houghton SG; Nelson LG; Swain JM; Nesset EM; Kendrick ML; Thompson GB; Murr MM; Nichols FC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):475-80. PubMed ID: 16925273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anatomic findings and outcomes after antireflux procedures in morbidly obese patients undergoing laparoscopic conversion to Roux-en-Y gastric bypass.
    Kellogg TA; Andrade R; Maddaus M; Slusarek B; Buchwald H; Ikramuddin S
    Surg Obes Relat Dis; 2007; 3(1):52-7; discussion 58-9. PubMed ID: 17116426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of bariatric surgery on the esophagus.
    Savarino E; Marabotto E; Savarino V
    Curr Opin Gastroenterol; 2018 Jul; 34(4):243-248. PubMed ID: 29846257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.